Hepatology Forum

Scope & Guideline

Elevating hepatology insights for practitioners and scholars.

Introduction

Welcome to your portal for understanding Hepatology Forum, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1307-5888
PublisherKARE PUBL
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationHEPATOL FORUM / Hepatol. Forum
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGoztepe Mah. Fahrettin Kerim Gokay Caddesi. No: 200/A D:2 Cemenzar - Kadkoy, ISTANBUL 34720, Turkiye

Aims and Scopes

The journal 'Hepatology Forum' focuses on advancing the understanding and treatment of liver diseases through innovative research and clinical practice. Its aims and scopes encompass a wide range of topics related to hepatology, aiming to bridge the gap between laboratory findings and clinical applications.
  1. Liver Disease Mechanisms and Pathophysiology:
    Research exploring the underlying mechanisms of various liver diseases, including hepatitis, fatty liver diseases, and liver cancer, contributes to a deeper understanding of disease progression and management.
  2. Transplantation and Surgical Interventions:
    The journal emphasizes studies on liver transplantation, including donor selection, surgical techniques, and post-operative care, which are crucial for improving patient outcomes.
  3. Innovative Diagnostic Approaches:
    The publication covers advancements in diagnostic methodologies, such as imaging techniques and biomarker identification, enhancing the accuracy and efficiency of liver disease diagnoses.
  4. Therapeutic Strategies and Clinical Trials:
    A significant focus is placed on novel therapeutic interventions for liver diseases, including pharmacological treatments, dietary modifications, and alternative therapies, supported by clinical trial data.
  5. Public Health and Epidemiology:
    The journal addresses the epidemiological aspects of liver diseases, including prevalence studies and risk factor assessments, to inform public health strategies and resource allocation.
  6. Genetic and Molecular Research:
    Research investigating genetic predispositions and molecular pathways involved in liver diseases is a core area, contributing to personalized medicine approaches in hepatology.
The journal has observed several emerging themes that reflect the evolving landscape of hepatology research. These trends indicate a growing interest in innovative methodologies and pressing clinical issues.
  1. Metabolic Dysfunction-Associated Liver Disease (MASLD):
    Recent publications indicate a significant increase in research focused on metabolic dysfunction-associated liver disease, reflecting its rising prevalence and importance in the context of global health.
  2. Artificial Intelligence in Hepatology:
    The integration of artificial intelligence for predictive modeling and diagnostic purposes in liver disease management is gaining traction, highlighting a trend towards utilizing technology in clinical practice.
  3. Impact of COVID-19 on Liver Health:
    The exploration of COVID-19's effects on liver diseases, including complications and management strategies, has emerged as a critical area of research in light of the pandemic's ongoing impact.
  4. Personalized Medicine and Genetic Studies:
    There is a growing trend towards personalized medicine, with an emphasis on genetic studies that tailor treatment approaches based on individual patient profiles and genetic backgrounds.
  5. Non-Invasive Assessment Techniques:
    The rise of non-invasive techniques for assessing liver conditions, such as elastography and biochemical markers, reflects an emerging focus on improving patient comfort and clinical outcomes.

Declining or Waning

While 'Hepatology Forum' continues to cover a broad spectrum of topics, certain areas have shown a decline in publication frequency and relevance over recent years. This may reflect shifting clinical priorities or advancements in other research domains.
  1. Traditional Pharmaceutical Treatments:
    There appears to be a waning focus on older, conventional pharmacological treatments for liver diseases, possibly due to the emergence of more effective and targeted therapies.
  2. Basic Science Without Clinical Application:
    Research that primarily explores basic science without clear clinical implications or applications is becoming less prominent, as the journal increasingly emphasizes translational research.
  3. Case Reports of Rare Conditions:
    While case reports provide valuable insights, the frequency of publications on rare liver conditions has diminished, likely as the journal prioritizes studies with broader clinical relevance.

Similar Journals

WORLD JOURNAL OF GASTROENTEROLOGY

Elevating research in gastrointestinal medicine.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1007-9327Frequency: 48 issues/year

WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Transforming gastroenterology with cutting-edge research.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

Translational Gastroenterology and Hepatology

Unlocking Innovations for Liver and Gut Health.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Canadian Journal of Gastroenterology and Hepatology

Elevating Standards in Gastroenterology and Hepatology Research
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

Frontline Gastroenterology

Championing Excellence in Gastroenterological Research
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

Hepatobiliary & Pancreatic Diseases International

Fostering collaboration for a healthier future in gastroenterology.
Publisher: ELSEVIERISSN: 1499-3872Frequency: 6 issues/year

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Pediatric Gastroenterology Hepatology & Nutrition

Advancing pediatric health through innovative research.
Publisher: KOREAN SOC PEDIATRIC GASTROENTEROLOGY & NUTRITIONISSN: 2234-8646Frequency: 6 issues/year

Pediatric Gastroenterology Hepatology & Nutrition is a pivotal academic journal published by the Korean Society of Pediatric Gastroenterology & Nutrition, focusing on the critical fields of pediatric gastroenterology, hepatology, and nutrition. Located in South Korea, this journal aims to disseminate high-quality research, review articles, and clinical studies to advance knowledge and practice in the care of children with gastrointestinal and nutritional disorders. With a Converged Years span from 2012 to 2024 and categorized in the Q2 and Q3 quartiles in 2023 across multiple related fields, the journal holds a significant position within the academic community, reflecting its impactful contribution to the discipline. Although currently not open access, the journal ensures that content is accessible to a broad audience through various institutional subscriptions. The journal appeals to researchers, healthcare professionals, and students alike, providing an essential platform for the exchange of innovative ideas and research findings aimed at improving pediatric patient care.

Gastroenterology Research and Practice

Pioneering Insights in Gastroenterology and Hepatology
Publisher: HINDAWI LTDISSN: 1687-6121Frequency:

Gastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.

International Journal of Hepatology

Pioneering insights for a healthier liver tomorrow.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Clinics in Liver Disease

Empowering liver health with cutting-edge insights.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.